MetaCap

Humana Financial Ratios

NYSE: HUMHealth CareMedical SpecialitiesUSD

431.87+44.75 (+11.56%)

At close: Oct 9, 4:03 PM ET · Delayed 15 min

Humana ratio analysis

Humana earned a net margin of 0.9% in FY 2025, down from 1.0% a year earlier. Return on equity reached 6.7%, meaning Humana generated 0.07 dollars of profit for every dollar of shareholders' equity. Debt-to-equity stood at 0.70 versus 0.72 the year before, and the current ratio was 2.00.

At the end of FY 2025, HUM traded at 26.9 times earnings; across the 10 fiscal years shown, its year-end P/E ranged from 14.8 to 50.1, with a median of 22.8. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.

Summary generated from market data by MetaCap's automated system. Methodology

Humana financial ratios (annual)

Humana annual financial ratios
RatioFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
P/E ratio (at fiscal year end)26.8826.3022.8923.2020.4616.2118.1522.7514.7650.13
Price / sales0.250.270.530.700.720.700.750.670.670.56
Price / book1.801.933.494.233.713.954.063.743.642.85
Operating margin2.1%2.2%3.8%4.1%3.8%6.5%4.9%5.4%7.9%3.2%
Net margin0.9%1.0%2.3%3.0%3.5%4.4%4.2%3.0%4.6%1.1%
Free cash flow margin0.3%2.0%2.8%3.7%1.1%6.1%7.0%2.7%6.6%2.6%
Return on equity (ROE)6.7%7.4%15.3%18.3%18.2%24.5%22.5%16.6%24.9%5.7%
Return on assets (ROA)2.4%2.6%5.3%6.5%6.6%9.6%9.3%6.6%9.0%2.4%
Debt / equity0.700.720.720.730.780.490.470.600.500.38
Current ratio2.001.761.591.521.621.771.821.681.852.07
Revenue growth10.1%10.7%14.5%11.8%7.7%18.9%14.0%5.8%-1.1%0.2%
EPS growth-1.4%-50.1%-9.4%-2.6%-10.4%25.9%65.3%-27.7%313.0%-51.8%

Related